INS and metabolic syndrome: Insulin sensitive MHO-MetS patients, in fact, exhibited lower fasting and post-load plasma insulin levels (Figure 1B), higher ISI and DI, and lower IGI (Figure 1C) compared to both insulin resistant MHO-MetS and MUO-MetS, and exhibited an insulin profile similar to those with MHO-IRes (Figure 1A,B).